reference/27335445

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27335445

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.\|Review
endingPage	S25
issn	1432-0843 0344-5704
issueIdentifier	Suppl 1
pageRange	S19-S25
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	S19
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_47542af33c1d393f2a4d05e17829fe70 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cf92f6147c296fbe704642ec404d2899
bibliographicCitation	Osheroff N, Corbett AH, Elsea SH, Westergaard M. Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes. Cancer Chemotherapy and Pharmacology. 1994 Jan;34(Suppl 1):s19–25. doi: 10.1007/bf00684859.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5dd092df1764b3948c2cc8efdc20398 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_702ad90e9ca0fe96584438260a6c98bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2f01cda234f52ba9794d42642d54d6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_863b4b02405aff870804823db860653d
date	199401
identifier	https://doi.org/10.1007/bf00684859 https://pubmed.ncbi.nlm.nih.gov/8070023
isPartOf	https://portal.issn.org/resource/ISSN/1432-0843 https://portal.issn.org/resource/ISSN/0344-5704 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes
discusses	http://id.nlm.nih.gov/mesh/M0381050 http://id.nlm.nih.gov/mesh/M0006644 http://id.nlm.nih.gov/mesh/M0191114 http://id.nlm.nih.gov/mesh/M0011762 http://id.nlm.nih.gov/mesh/M0029441 http://id.nlm.nih.gov/mesh/M0007930 http://id.nlm.nih.gov/mesh/M0545767 http://id.nlm.nih.gov/mesh/M0023650 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0001329 http://id.nlm.nih.gov/mesh/M0372253 http://id.nlm.nih.gov/mesh/M0001039
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000633 http://id.nlm.nih.gov/mesh/D004249 http://id.nlm.nih.gov/mesh/D004250Q000378 http://id.nlm.nih.gov/mesh/D024841
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000677Q000633 http://id.nlm.nih.gov/mesh/D004247Q000187 http://id.nlm.nih.gov/mesh/D059005 http://id.nlm.nih.gov/mesh/D000890Q000633 http://id.nlm.nih.gov/mesh/D004247Q000378 http://id.nlm.nih.gov/mesh/D007529Q000633 http://id.nlm.nih.gov/mesh/D005047Q000633 http://id.nlm.nih.gov/mesh/D000970Q000145 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008961 http://id.nlm.nih.gov/mesh/D015363Q000633 http://id.nlm.nih.gov/mesh/D019833 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280961 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119367 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2179

Showing number of triples: 1 to 64 of 64.